https://www.openbell.ai/ 2026-10-12T10:30:43.219Z hourly 1.0 https://www.openbell.ai/support 2026-10-12T10:30:43.219Z monthly 0.7 https://www.openbell.ai/privacy 2026-10-12T10:30:43.219Z monthly 0.5 https://www.openbell.ai/terms 2026-10-12T10:30:43.219Z monthly 0.5 https://www.openbell.ai/feed.json 2026-10-12T10:30:43.219Z hourly 0.8 https://www.openbell.ai/news/FSLR:1791800796174 2026-10-12T10:26:36.174Z daily 0.9 https://cdn.brandfetch.io/FSLR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Upgrades First Solar to Buy, Raises Price Target to $270 Truist Securities has upgraded First Solar (NASDAQ: FSLR) from a Hold to a Buy rating. The price target for the stock has been increased from $229 to $270. https://www.openbell.ai/news/ANTW:1791800783119 2026-10-12T10:26:23.119Z daily 0.9 https://cdn.brandfetch.io/ANTW/w/400/h/400?c=1idopYfmtR7ZKg8QMud AI Bubble Ready to Burst? Investor Raises Alarm Over Anthropic's Sky-High Valuation OpenAI has postponed its IPO plans until 2027 due to concerns over AI safety, while Anthropic is preparing for a potential IPO in mid-November 2026, aiming for a valuation of $2 trillion and a capital raise of up to $100 billion. Portfolio manager John Belton emphasizes that revenue growth at these companies is crucial for the AI market, with their combined annual recurring revenue nearing $150 billion. However, Tusk warns of an AI bubble, suggesting that Anthropic's valuation, trading at approximately 27 times revenue, may not be sustainable without consistent revenue growth. https://www.openbell.ai/news/QNRX:1791800385156 2026-10-12T10:19:45.156Z daily 0.9 https://cdn.brandfetch.io/QNRX/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Initiates Coverage On Quoin Pharmaceuticals with Buy Rating, Announces Price Target of $14 BTIG analyst Jeet Mukherjee has initiated coverage on Quoin Pharmaceuticals (NASDAQ: QNRX) with a Buy rating. The analyst has set a price target of $14 for the company's stock. https://www.openbell.ai/news/NOW:1791800209558 2026-10-12T10:16:49.558Z daily 0.9 https://cdn.brandfetch.io/NOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Reiterates Buy on ServiceNow, Maintains $170 Price Target BTIG analyst Allan Verkhovski has reiterated a Buy rating on ServiceNow (NYSE: NOW) and maintained a price target of $170 for the stock. This endorsement reflects confidence in the company's performance and market position. https://www.openbell.ai/news/SNOW:1791800101811 2026-10-12T10:15:01.811Z daily 0.9 https://cdn.brandfetch.io/SNOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Reiterates Buy on Snowflake, Maintains $450 Price Target Needham analyst Mike Cikos has reiterated a Buy rating on Snowflake (NYSE: SNOW) and maintained a price target of $450. This endorsement reflects confidence in the company's performance and potential for growth. https://www.openbell.ai/news/TMUS:1791799922205 2026-10-12T10:12:02.205Z daily 0.9 https://cdn.brandfetch.io/TMUS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Raymond James Upgrades T-Mobile US to Outperform, Announces $170 Price Target Raymond James analyst Ric Prentiss has upgraded T-Mobile US (NASDAQ: TMUS) from Market Perform to Outperform. The firm has set a price target of $170 for the stock. https://www.openbell.ai/news/VJET:1791799737907 2026-10-12T10:08:57.907Z daily 0.9 https://cdn.brandfetch.io/VJET/w/400/h/400?c=1idopYfmtR7ZKg8QMud Flyte Aviation Reports Preliminary Q3 Sales Of $2.15M, Up 110% QoQ Flyte Aviation reported preliminary Q3 sales of $2.15 million, marking a 110% increase quarter-over-quarter. Aviation revenue grew 150% sequentially from Q2 2026, reaching approximately $1.87 million. Additionally, the user base of their proprietary digital aviation platform surged by 185% since its redesign in late May 2026, adding over 13,000 new accounts and exceeding 20,000 total users. https://www.openbell.ai/news/SI:1791799724021 2026-10-12T10:08:44.021Z daily 0.9 https://cdn.brandfetch.io/SI/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Maintains Buy on Shoulder Innovations, Raises Price Target to $27 BTIG analyst Ryan Zimmerman has maintained a 'Buy' rating on Shoulder Innovations (NYSE: SI) and increased the price target from $26 to $27. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/MEDS:1791799479899 2026-10-12T10:04:39.899Z daily 0.9 https://cdn.brandfetch.io/MEDS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Datameds AI Subsidiary Helomics Receives Medicaid Coverage Determination In Gynecologic Cancers For The ChemoFx Assay In Gynecologic Cancers DataMeds AI, Inc. (NASDAQ: MEDS) announced that its subsidiary Helomics Corporation has received Medicaid coverage for the ChemoFx Assay in gynecologic cancers, which assesses how live tumor cells respond to chemotherapy. This coverage was reviewed by Humana's Medicaid Coverage Policy Adoption Forum and is effective for specific cancer indications. The ChemoFx Assay is considered cost-effective, with an incremental cost-effectiveness ratio of $6,206 per life-year saved for patients with recurrent epithelial ovarian cancer. The assay is billed under CPT codes 81535 and 81536, and Helomics is positioned to support increased volume as coverage expands. https://www.openbell.ai/news/BXP:1791799447197 2026-10-12T10:04:07.197Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Miniature-House-Models-On-Graph-Indicati.jpg?width=250&height=187 Top 3 Real Estate Stocks That Are Set To Fly This quarter The article highlights three oversold real estate stocks: Weyerhaeuser Co (NYSE: WY) with an RSI of 29.6, which has fallen 14% over the past month and closed at $19.10; Jones Lang LaSalle Inc (NYSE: JLL) with an RSI of 27.7, down 13% recently, closing at $299.87; and BXP Inc (NYSE: BXP) with an RSI of 28.7, which has decreased 8% and closed at $59.05. Weyerhaeuser announced a strategic partnership with TimberHP to enhance wood-based building solutions, while JLL's price target was lowered by an analyst. BXP is set to release its third-quarter financial results on October 27. https://www.openbell.ai/news/GKOS:1791799170914 2026-10-12T09:59:30.914Z daily 0.9 https://cdn.brandfetch.io/GKOS/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Maintains Buy on Glaukos, Raises Price Target to $205 BTIG analyst Ryan Zimmerman has maintained a Buy rating on Glaukos (NYSE: GKOS) and raised the price target from $202 to $205. This adjustment reflects confidence in the company's performance and future prospects. https://www.openbell.ai/news/USO:1791799106282 2026-10-12T09:58:26.282Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Saudi Eyes 10 Million Barrels a Day of Oil Pipe Capacity' - Bloomberg Saudi Arabia aims to increase its oil pipeline capacity to 10 million barrels per day. This strategic move is part of the country's efforts to enhance its oil export capabilities and meet growing global demand. The initiative may have significant implications for the oil market and could influence stock prices, including those of related companies such as USO. https://www.openbell.ai/news/TSLA:1791799061239 2026-10-12T09:57:41.239Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Tesla-robotaxi-Cybercab-and-Robovan-on-p.jpg?width=250&height=187 Tesla Robotaxi Fleet in Austin Soars 8x in a Month While Elon Musk Admits TSLA Is Still Working on Not Running Over Cats Tesla Inc. has expanded its Robotaxi fleet in Austin to over 300 Cybercabs, marking an 8x increase in just 30 days. CEO Elon Musk acknowledged challenges with nighttime visibility for the service, emphasizing the importance of avoiding accidents with pets. Additionally, Tesla has rebranded its Full Self-Driving service in Europe to 'Tesla Assisted Driving' following regulatory feedback. TSLA shares rose 0.09% to $383.03 in pre-market trading. https://www.openbell.ai/news/DXCM:1791799050379 2026-10-12T09:57:30.379Z daily 0.9 https://cdn.brandfetch.io/DXCM/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Maintains Buy on DexCom, Raises Price Target to $96 BTIG analyst Ryan Zimmerman has maintained a 'Buy' rating on DexCom (NASDAQ: DXCM) and increased the price target from $90 to $96. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/ASBH:1791798979765 2026-10-12T09:56:19.765Z daily 0.9 https://cdn.brandfetch.io/ASBH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Piper Sandler Initiates Coverage On American Savings Bank with Overweight Rating, Announces Price Target of $20 Piper Sandler analyst Matthew Clark has initiated coverage on American Savings Bank (NYSE: ASBH) with an Overweight rating. The firm has set a price target of $20 for the bank's stock. https://www.openbell.ai/news/CARL:1791798975234 2026-10-12T09:56:15.234Z daily 0.9 https://cdn.brandfetch.io/CARL/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Maintains Buy on Carlsmed, Raises Price Target to $24 BTIG analyst Ryan Zimmerman has reiterated a Buy rating on Carlsmed (NASDAQ: CARL) and increased the price target from $23 to $24. This adjustment reflects positive sentiment towards the company's performance and future prospects. https://www.openbell.ai/news/RCEL:1791798917842 2026-10-12T09:55:17.842Z daily 0.9 https://cdn.brandfetch.io/RCEL/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Maintains Buy on AVITA Medical, Raises Price Target to $15 BTIG analyst Ryan Zimmerman has maintained a Buy rating on AVITA Medical (NASDAQ: RCEL) and raised the price target from $11 to $15. This adjustment reflects a positive outlook for the company's performance. https://www.openbell.ai/news/ATRC:1791798862976 2026-10-12T09:54:22.976Z daily 0.9 https://cdn.brandfetch.io/ATRC/w/400/h/400?c=1idopYfmtR7ZKg8QMud BTIG Maintains Buy on AtriCure, Raises Price Target to $63 BTIG analyst Ryan Zimmerman has maintained a Buy rating on AtriCure (NASDAQ: ATRC) and increased the price target from $55 to $63. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/SNPS:1791798261499 2026-10-12T09:44:21.499Z daily 0.9 https://cdn.brandfetch.io/SNPS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Maintains Buy on Synopsys, Raises Price Target to $620 Needham analyst Charles Shi has maintained a 'Buy' rating on Synopsys (NASDAQ: SNPS) and increased the price target from $580 to $620. This adjustment reflects a positive outlook for the company's performance. https://www.openbell.ai/news/SKYA:1791798211918 2026-10-12T09:43:31.918Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Investors-Show-Virtual-Screen-Stock-Mark.jpg?width=250&height=187 Why Is SkyAI Stock Surging Monday? SkyAI, Inc. (NASDAQ: SKYA) stock surged 24.68% to $2.26 in premarket trading following the announcement of a cash tender offer worth up to $201 million, aimed at repurchasing up to 95% of its outstanding common shares and warrants at $3 per share. The offer represents a 65% premium to the company's closing price on October 9 and is expected to commence around October 15, lasting for 10 business days. Additionally, SkyAI's board rejected a takeover proposal from Forward Industries, citing undervaluation concerns, and plans to fund the buyback using existing cash and proceeds from recent Solana token sales. https://www.openbell.ai/news/HXL:1791798171997 2026-10-12T09:42:51.997Z daily 0.9 https://cdn.brandfetch.io/HXL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Seaport Global Upgrades Hexcel to Buy, Announces $104 Price Target Seaport Global analyst Richard Safran has upgraded Hexcel (NYSE: HXL) from a Neutral rating to a Buy rating. Additionally, a price target of $104 has been set for the company's stock. https://www.openbell.ai/news/HUBG:1791798016076 2026-10-12T09:40:16.076Z daily 0.9 https://cdn.brandfetch.io/HUBG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Baird Upgrades Hub Group to Outperform, Maintains Price Target to $29 Baird analyst Daniel Moore has upgraded Hub Group (NASDAQ: HUBG) from Neutral to Outperform while maintaining the price target at $29. This upgrade indicates a positive outlook for the company's performance in the market. https://www.openbell.ai/news/DAVA:1791797874900 2026-10-12T09:37:54.900Z daily 0.9 https://cdn.brandfetch.io/DAVA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Needham Suspends Buy Rating on Endava, Maintains $5 Price Target Needham has suspended its Buy rating on Endava (NYSE: DAVA) while maintaining a price target of $5 for the company's stock. This decision reflects a reassessment of the company's market position and outlook. https://www.openbell.ai/news/IREN:1791797662821 2026-10-12T09:34:22.821Z daily 0.9 https://cdn.brandfetch.io/IREN/w/400/h/400?c=1idopYfmtR7ZKg8QMud IREN Reportedly Signed Multiyear Cloud Deal With Anthropic IREN has reportedly signed a multiyear cloud deal with Anthropic, according to a report by Reuters citing The Information. The specifics of the financial terms of the deal have not been disclosed. This partnership may enhance IREN's cloud service offerings and potentially impact its market position. https://www.openbell.ai/news/TSLA:1791796968792 2026-10-12T09:22:48.792Z daily 0.9 https://cdn.brandfetch.io/TSLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Elon Musk Says Terafab Could Rank Among ‘Top 20 of Country GDPs’ as Tesla and SpaceX Build Massive Texas Chip Empire Elon Musk announced that the Terafab project, a semiconductor complex being developed by Tesla and SpaceX in Texas, could produce output comparable to the GDP of one of the world's top 20 economies. The first phase of the project represents over $16.8 billion in investment and is expected to create 3,000 jobs, with SpaceX receiving a $30 million grant from the Texas Enterprise Fund. The facility aims to supply chips for Tesla's robots and SpaceX's spacecraft, with plans for it to span over 100 million square feet. https://www.openbell.ai/news/TSLA:1791796952781 2026-10-12T09:22:32.781Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Elon-Musk--founder--CEO--and-chief-engin.jpg?width=250&height=187 Elon Musk Says Terafab Could Rank Among ‘Top 20 of Country GDPs’ as Tesla and SpaceX Build Massive Texas Chip Empire Elon Musk announced that the Terafab project, a semiconductor complex being developed by Tesla and SpaceX in Texas, could generate output comparable to the GDP of one of the world's top 20 economies. The project is expected to involve an investment of over $16.8 billion and create 3,000 jobs, with Texas awarding SpaceX a $30 million grant. The facility aims to supply chips for Tesla's robots and SpaceX's spacecraft, with plans for a 100 million square foot site that will vertically integrate manufacturing, packaging, and testing. https://www.openbell.ai/news/TSLA:1791796758817 2026-10-12T09:19:18.817Z daily 0.9 https://cdn.brandfetch.io/TSLA/w/400/h/400?c=1idopYfmtR7ZKg8QMud NHTSA Opens Defect Petition Into Estimated 1K Tesla Robotaxi Vehicles Over Allegations Of Exceeding Posted Speed Limits In Active School Zones The National Highway Traffic Safety Administration (NHTSA) has initiated a defect petition concerning approximately 1,000 Tesla Robotaxi vehicles. The investigation is based on allegations that these vehicles may exceed posted speed limits in active school zones. This development could have implications for Tesla's regulatory compliance and public perception. https://www.openbell.ai/news/KTOS:1791796719729 2026-10-12T09:18:39.729Z daily 0.9 https://cdn.brandfetch.io/KTOS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Kratos And Airbus Complete First European Flight Of U740 Valkyrie, Staying On Track To Deliver Combat-Ready Uncrewed CCA By 2029 openbell Financial News https://www.openbell.ai/news/FNMA:1791795416357 2026-10-12T08:56:56.357Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Fannie-Mae-Freddie-Mac.jpg?width=250&height=187 Michael Burry Warns Fannie Mae and Freddie Mac Could Become ‘Worthless’ as Trump-Era Gains Collapse Under Fresh Pressure Michael Burry has warned that Fannie Mae (OTC: FNMA) and Freddie Mac (OTC: FMCC) could become 'worthless' as their stock prices have significantly declined, erasing gains made since Donald Trump's election. Both stocks have recently shown a 'giant head-and-shoulders-and-elbows top' pattern, indicating a severe technical breakdown, with FNMA down 31.64% over the last month and 66.75% year-to-date, while FMCC is down 29.90% in a month and 68.84% year-to-date. Burry also highlighted risks related to the government's senior preferred stock liquidation preference, which could lead to a 90% dilution for common shareholders. https://www.openbell.ai/news/DHT:1791794559669 2026-10-12T08:42:39.669Z daily 0.9 https://cdn.brandfetch.io/DHT/w/400/h/400?c=1idopYfmtR7ZKg8QMud DHT Holdings Estimates Q3 TCE Earnings At $141,300 Per Day, With Spot VLCCs At $167,100 And Time Charter At $114,200; Q4 Spot Days 50% Booked At $509,100 openbell Financial News https://www.openbell.ai/news/FLYE:1791793778531 2026-10-12T08:29:38.531Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/The-Real-Villains-No-Longer-Hide.jpg?width=250&height=187 Why J-Star Holding Shares Are Trading Higher By Around 128%; Here Are 20 Stocks Moving Premarket Shares of J-Star Holding Co Ltd (NASDAQ: YMAT) increased by 127.9% to $2.94 in pre-market trading following the announcement of corporate capital initiatives aimed at funding its planned U.S. expansion for drone frame manufacturing. This significant rise in stock price reflects investor confidence in the company's strategic growth plans. https://www.openbell.ai/news/NAVN:1791793637805 2026-10-12T08:27:17.805Z daily 0.9 https://cdn.brandfetch.io/NAVN/w/400/h/400?c=1idopYfmtR7ZKg8QMud Navan Chosen By Investec To Consolidate Travel Operations, Cut Administrative Work And Improve Booking Experience For Dual-Listed Bank’s Workforce openbell Financial News https://www.openbell.ai/news/FCPT:1791793575342 2026-10-12T08:26:15.342Z daily 0.9 https://cdn.brandfetch.io/FCPT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Friday, FCPT Acquires Indiana Automotive Service Property Leased To National Operator For $2.3M Via Sale-Leaseback Under Long-Term Triple Net Lease openbell Financial News https://www.openbell.ai/news/SVC:1791793552981 2026-10-12T08:25:52.981Z daily 0.9 https://cdn.brandfetch.io/SVC/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Friday, Service Properties Trust Confirms Unsolicited $2.0B Cash Proposal From TKO To Acquire Its Hospitality Portfolio, Says Board Will Review openbell Financial News https://www.openbell.ai/news/BEP:1791793492648 2026-10-12T08:24:52.648Z daily 0.9 https://cdn.brandfetch.io/BEP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Friday, Brookfield Renewable Proposes To Combine BEP And BEPC Into Single Corporation Brookfield Renewable Partners Inc., With BEP Meeting Rescheduled To October 29 Brookfield Renewable Partners Inc. has proposed to combine its entities BEP and BEPC into a single corporation. The unitholder meeting to vote on this proposal has been rescheduled to October 29, 2026, with votes received so far showing strong support for the merger. Unitholders needing assistance with voting can contact the proxy solicitation agent, Laurel Hill Advisory Group. https://www.openbell.ai/news/MNKD:1791793106346 2026-10-12T08:18:26.346Z daily 0.9 https://cdn.brandfetch.io/MNKD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Friday, MannKind’s Under-10-Second Furoscix ReadyFlow Autoinjector Shows Urine Output Comparable To IV Furosemide In New HFSA 2026 Analyses, Supporting Outpatient Edema Management In Heart Failure And CKD MannKind's Furoscix ReadyFlow autoinjector has demonstrated urine output comparable to IV furosemide, supporting its use in outpatient management of heart failure and chronic kidney disease (CKD). The analyses show consistent bioavailability and diuretic responses, facilitating flexible administration in clinical settings. These findings build on the FDA approval and U.S. launch of Furoscix ReadyFlow in July 2026, marking it as the first autoinjector for IV-equivalent diuretic therapy. https://www.openbell.ai/news/ASTH:1791792456151 2026-10-12T08:07:36.151Z daily 0.9 https://cdn.brandfetch.io/ASTH/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Saturday, Verda Healthcare Partners With AstranaCare Partners Of Arizona And Texas To Extend Culturally Responsive Medicare Advantage Care To Underserved Communities openbell Financial News https://www.openbell.ai/news/RHHBY:1791792328944 2026-10-12T08:05:28.944Z daily 0.9 https://cdn.brandfetch.io/RHHBY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Saturday, FDA Accepts Genentech’s Vamikibart BLA For Uveitic Macular Edema With Approval Decision Expected By July 2027, Following Phase III Data Showing Sustained Improvements At 52 Weeks The FDA has accepted Genentech's Biologics License Application (BLA) for Vamikibart, targeting Uveitic Macular Edema (UME), with a decision expected by July 2027. Phase III studies, MEERKAT and SANDCAT, showed sustained improvements in vision and reductions in macular thickness at 52 weeks. UME is a leading cause of severe vision loss in uveitis patients, highlighting the importance of this treatment. https://www.openbell.ai/news/SPCX:1791792227178 2026-10-12T08:03:47.178Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/SpaceX-starships-in-launch-position-at-t.jpg?width=250&height=187 Top Analyst Calls Elon Musk’s Next Starship Flight SpaceX’s ‘Biggest Test’ Yet — One Launch Could Replace a Month of Falcon 9 Missions Morgan Stanley analyst Adam Jonas has described SpaceX's upcoming Starship Flight Test 15 as the company's 'biggest test' for reusability since its IPO, suggesting that one launch could replace a month of Falcon 9 missions. Jonas indicated that each Starship launch would significantly reduce launch costs and increase payload capacity, potentially creating new markets. Elon Musk has stated that the launch is expected in about four to six weeks, following a minor engine glitch during the previous test. https://www.openbell.ai/news/TTE:1791790632601 2026-10-12T07:37:12.601Z daily 0.9 https://cdn.brandfetch.io/TTE/w/400/h/400?c=1idopYfmtR7ZKg8QMud KKR And TotalEnergies Agree To Add 700 MW Solar Portfolio To 50/50 JV Holding 1.4 GW At $1.2B Enterprise Value openbell Financial News https://www.openbell.ai/news/ASX:1791790591634 2026-10-12T07:36:31.634Z daily 0.9 https://cdn.brandfetch.io/ASX/w/400/h/400?c=1idopYfmtR7ZKg8QMud ASE Technology Q3 Net Revenues $7.642B Up 34.9% From $5.663B YoY, Up 26.3% Sequentially; September Net Revenues $2.777B Up 39.2% From $1.995B YoY openbell Financial News https://www.openbell.ai/news/BNBUSD:1791790441482 2026-10-12T07:34:01.482Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Ukraine--Rovno---On-January-23-Ledger-Ha.jpg?width=250&height=187 Hackers ‘Apparently Bought the Reseller,’ Says Changpeng Zhao — Ledger Issues Advisory After Reported $86 Million Crypto Losses Ledger has reported an unauthorized hardware implant sold by Malaysian reseller CryptoBilis, resulting in over $86 million in cryptocurrency losses. The company has paused all sales and shipments from CryptoBilis and is advising customers not to initialize devices purchased from the reseller. Binance founder Changpeng Zhao suggested that hackers may have acquired CryptoBilis and enforced a non-disclosure agreement to conceal the incident. Ledger's direct sales channels remain unaffected as they reach out to impacted users for support. https://www.openbell.ai/news/DAL:1791790428554 2026-10-12T07:33:48.554Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/President-Donald-Trump-stops-to-speak-wi.jpg?width=250&height=187 Trump Admin Warns US Airlines of Saudi Airspace Risks After Deadly Riyadh Airport Attacks, Putting Delta's Launch Next Week in Doubt The Trump administration has warned U.S. airlines to exercise caution when flying over Saudi Arabia due to military activity and navigation-system interference, following deadly attacks on Riyadh's King Khalid International Airport that killed 13 and injured over 300. The FAA issued a notice through December 10, affecting U.S.-registered aircraft. Delta Air Lines, which plans to launch nonstop service from Atlanta to Riyadh on October 23, is now facing uncertainty regarding the launch due to safety concerns, as the airport remains closed and further attacks have occurred. https://www.openbell.ai/news/NOK:1791790063849 2026-10-12T07:27:43.849Z daily 0.9 https://cdn.brandfetch.io/NOK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nokia Becomes First Vendor With 16-Port Line Card Supporting GPON And 10G, 25G, 50G PON On Every Port For AI-Ready Fiber Broadband Nokia has launched a 16-port line card solution that supports GPON, 10G, 25G, and 50G PON on every port, making it the first vendor to offer such flexibility. This solution, built on Nokia’s Quillion chipset, aims to facilitate mass-market deployment of fiber access speeds up to 50Gbps and is designed to meet the connectivity demands of the AI era. General availability of this industry-first multi-PON solution is planned for 2027. https://www.openbell.ai/news/IEF:1791788827086 2026-10-12T07:07:07.086Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/10/12/Russia--Moscow--11-27-2017-A-Lebanese-am.jpg?width=250&height=187 'Black Swan' Author Nassim Taleb Says Trump 'Behind a Debt Spiral' That Is 'Unavoidable' — 'It Is Just Fiscal Incompetence' Nassim Nicholas Taleb stated that the U.S. is in an unavoidable debt spiral, attributing a 42% increase in national debt and a 2% rise in borrowing costs to President Donald Trump's fiscal policies. The national debt currently stands at $40.36 trillion, with a federal deficit of approximately $2 trillion for fiscal 2026. Taleb criticized Treasury Secretary Scott Bessent's downplaying of the situation, labeling it as fiscal incompetence rather than a partisan issue. https://www.openbell.ai/news/BBIO:1791788686248 2026-10-12T07:04:46.248Z daily 0.9 https://cdn.brandfetch.io/BBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Sunday, BridgeBio’s Encaleret Raises Bone Turnover, With 100% Of Phase 3 CALIBRATE Participants Reporting Improvement In At Least One ADH1 Symptom Versus 46% On Standard Of Care BridgeBio's drug Encaleret has shown promising results in a Phase 3 trial, with 100% of participants reporting improvements in at least one symptom of ADH1, compared to 46% in the standard care group. The FDA has accepted the New Drug Application (NDA) for Encaleret and granted it Priority Review, with a target action date set for May 8, 2027. Additionally, the company has initiated a Phase 3 study, RECLAIM-HP, for chronic hypoparathyroidism. https://www.openbell.ai/news/ABBV:1791788629308 2026-10-12T07:03:49.308Z daily 0.9 https://cdn.brandfetch.io/ABBV/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Sunday, AbbVie’s SKYRIZI Shows Sustained Endoscopic Outcomes Through 144 Weeks In Crohn’s And 74.5% Fistula Resolution At Five Years, While RINVOQ Real-World Data Show Remission In Advanced Crohn’s AbbVie's SKYRIZI has shown sustained endoscopic outcomes through 144 weeks in Crohn's disease patients, with a 74.5% fistula resolution rate at five years, according to new Phase 3 AFFIRM data. Additionally, real-world data for RINVOQ indicate successful disease control in patients with advanced Crohn's disease. The findings were presented at the American College of Gastroenterology 2026 Annual Scientific Meeting, underscoring AbbVie's commitment to addressing inflammatory bowel disease complexities. https://www.openbell.ai/news/BBIO:1791788191734 2026-10-12T06:56:31.734Z daily 0.9 https://cdn.brandfetch.io/BBIO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Sunday, BridgeBio Presents Acoramidis Data At HFSA 2026 Showing 18% Lower Composite Risk Versus Tafamidis In Real-World Study Of 2,684 ATTR-CM Patients And Mortality Rising After Cardiovascular Hospitalizations BridgeBio presented data at HFSA 2026 showing that acoramidis is associated with an 18% lower composite risk of death and hospitalization compared to tafamidis in a study of 2,684 ATTR-CM patients. The analysis indicated significant reductions in cardiovascular and all-cause hospitalizations, with a 27% lower risk for both cardiovascular and heart failure hospitalizations. These findings support the use of acoramidis as a preferred treatment option for patients with ATTR-CM, emphasizing the importance of hospitalization prevention in this population. https://www.openbell.ai/news/GT:1791786935145 2026-10-12T06:35:35.145Z daily 0.9 https://cdn.brandfetch.io/GT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Goodyear Tire, Cryo-Cell International and 3 Stocks to Watch Heading Into Monday Goodyear Tire & Rubber Co. appointed Joe Hinrichs as chairman of its Board of Directors, effective October 7, succeeding Laurette Koellner. Following this announcement, Goodyear shares increased by 0.2% to $4.69 in after-hours trading. Additionally, Cryo-Cell International reported third-quarter earnings of 16 cents per share, up from 9 cents per share a year ago, although sales slightly declined to $7.820 million. Cryo-Cell shares rose 4.6% to close at $4.36 on Friday. https://www.openbell.ai/news/SKYA:1791786663180 2026-10-12T06:31:03.180Z daily 0.9 https://cdn.brandfetch.io/SKYA/w/400/h/400?c=1idopYfmtR7ZKg8QMud Reported Sunday, SkyAI Plans Up To $201M Tender For Stock And Warrants At $3.00 Per Share, 46.37M Shares; Board Declines Forward Industries Proposal SkyAI plans to conduct a tender offer of up to $201 million to purchase up to 46.37 million shares and various warrants at a price of $3.00 per share, which represents a 65% premium over its closing share price on October 9, 2026, and over 100% premium to the 60-day volume-weighted average price. Additionally, the company's Board has rejected an unsolicited proposal from Forward Industries, citing that it undervalues SkyAI and is not in the best interests of shareholders.